This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Dec;44(4):459-77.

Pentostatin: future directions

W D Klohs¹, A J Kraker

Affiliations

PMID: 1480666

Review

Pentostatin: future directions

W D Klohs et al. Pharmacol Rev. 1992 Dec.

. 1992 Dec;44(4):459-77.

Authors

W D Klohs¹, A J Kraker

Affiliation

¹ Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, Michigan.

PMID: 1480666

No abstract available

PubMed Disclaimer

Similar articles

Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction.
Silva PH, Dillon D, Van Wylen DG. Silva PH, et al. Cardiovasc Res. 1995 May;29(5):616-23. Cardiovasc Res. 1995. PMID: 7606748
Mutagenesis of human adenosine deaminase to active forms that partially resist inhibition by pentostatin.
Ibrahim MM, Weber IT, Knudsen TB. Ibrahim MM, et al. Biochem Biophys Res Commun. 1995 Apr 17;209(2):407-16. doi: 10.1006/bbrc.1995.1518. Biochem Biophys Res Commun. 1995. PMID: 7733907
Therapeutic potential for transient inhibition of adenosine deaminase in systemic inflammatory response syndrome.
Law WR, Valli VE, Conlon BA. Law WR, et al. Crit Care Med. 2003 May;31(5):1475-81. doi: 10.1097/01.CCM.0000063259.09580.D8. Crit Care Med. 2003. PMID: 12771621
Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
Spiers AS. Spiers AS. Haematologia (Budap). 1996;27(2):55-84. Haematologia (Budap). 1996. PMID: 14651224 Review.
A new chemotherapeutic agent: deoxycoformycin (pentostatin).
Dillman RO. Dillman RO. Semin Hematol. 1994 Jan;31(1):16-27. Semin Hematol. 1994. PMID: 8122134 Review. No abstract available.

See all similar articles

Cited by

The transition to magic bullets - transition state analogue drug design.
Evans GB, Schramm VL, Tyler PC. Evans GB, et al. Medchemcomm. 2018 Aug 28;9(12):1983-1993. doi: 10.1039/c8md00372f. eCollection 2018 Dec 1. Medchemcomm. 2018. PMID: 30627387 Free PMC article. Review.
A new strategy based on pharmacophore-based virtual screening in adenosine deaminase inhibitors detection and in-vitro study.
Bazl R, Ganjali MR, Saboury AA, Foroumadi A, Nourozi P, Amanlou M. Bazl R, et al. Daru. 2012 Oct 22;20(1):64. doi: 10.1186/2008-2231-20-64. Daru. 2012. PMID: 23351306 Free PMC article.
Modulation by nicotinamide adenine dinucleotide of sympathetic and sensory-motor neurotransmission via P1-purinoceptors in the rat mesenteric arterial bed.
Ralevic V. Ralevic V. Br J Pharmacol. 1995 Apr;114(8):1541-8. doi: 10.1111/j.1476-5381.1995.tb14937.x. Br J Pharmacol. 1995. PMID: 7599921 Free PMC article.
Effect of adenosine deaminase inhibition with pentostatin on myocardial stunning in dogs.
McClanahan TB, Ignasiak DP, Martin BJ, Mertz TE, Gallagher KP. McClanahan TB, et al. Basic Res Cardiol. 1995 Mar-Apr;90(2):176-83. doi: 10.1007/BF00789447. Basic Res Cardiol. 1995. PMID: 7646420 Clinical Trial.
Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase.
DeGraw RT, Anderson BD. DeGraw RT, et al. Pharm Res. 2001 Sep;18(9):1270-6. doi: 10.1023/a:1013029726065. Pharm Res. 2001. PMID: 11683239

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database